Lorraine Kalia

Dr. Kalia MD PhD –Associate Professor, clinician scientist with a clinical practice and a basic science research program that both focus on the most common neurodegenerative movement disorder: Parkinson’s disease. She holds the Wolfond-Krembil Chair in Parkinson's Disease Research. Her research interest are to discover and develop such disease-modifying therapies for Parkinson’s disease that target the putative molecular pathways responsible for causing neurodegeneration.

Her career is built on a solid foundation of training which included MD/PhD training, neurology residency, and clinical and research fellowships in movement disorders. As an independent investigator, she has published 46 peer-reviewed papers (25 as first/senior author) and, to date, 7,508 citations and a h-index is 31 (Scopus). She has been awarded 18 operating grants, 2 equipment grants, and 2 salary awards as Principal Investigator or Co-Principal Investigator, totaling over $5 million.

She has trained 26 undergraduate/medical students, 4 graduate students, and 8 postdoctoral fellows in my lab. She is an invited speaker at 36 national or international meetings and at 20 public community events. She has received awards and recognition for my research, teaching, leadership, and contribution to community.

She was recently recruited to be the co-editor-in-chief for the Journal of Parkinson’s Disease to develop its basic science and translational research content. She was the recipient of the University of Toronto Goldie Travel Award Basic Science 2023.